Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GRPEL2P3 is a human pseudogene corresponding to GrpE-like 2, mitochondrial (E. coli) pseudogene 3. It is a genomic locus that resembles the GRPEL2 gene but does not encode a functional protein. Pseudogenes are DNA sequences derived from functional genes that have typically lost their ability to code for proteins due to mutations or other genomic alterations. There is no evidence of transcriptional activity, protein product, or disease relevance for GRPEL2P3. As a pseudogene, GRPEL2P3 does not encode a functional protein product, so it is generally not considered a therapeutic target, such as a receptor, enzyme, transporter, or similar. While GRPEL2P3 is a valid genomic entity (pseudogene), it is not a functional protein-coding gene or recognized drug target; queries about its therapeutic targeting, function, or drug interaction would be inappropriate or misleading.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GrpE-like 2, mitochondrial pseudogene 3 (GRPEL2P3).